Question 1

What does Mydecine Innovations Group do?

Accepted Answer

Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders.

Question 2

In what sectors does Mydecine Innovations Group operate?

Accepted Answer

Mydecine Innovations Group operates in Biotechnology, Life Science, Mental Health, Therapeutics.

Question 3

How many companies has Mydecine Innovations Group acquired?

Accepted Answer

Mydecine Innovations Group has made 1 acquisitions between 2020-2020, with a total disclosed deal value of $6.0M.

Question 4

What companies are owned by Mydecine Innovations Group?

Accepted Answer

Companies acquired by Mydecine Innovations Group include NeuroPharm.

Question 5

What are Mydecine Innovations Group's major acquisitions?

Accepted Answer

Mydecine Innovations Group's largest acquisitions include NeuroPharm ($6.0M, 2020).

Question 6

What is Mydecine Innovations Group's largest acquisition?

Accepted Answer

Mydecine Innovations Group's largest disclosed acquisition is NeuroPharm for $6.0M (2020).

Question 7

What was Mydecine Innovations Group's first acquisition?

Accepted Answer

Mydecine Innovations Group's first recorded acquisition was NeuroPharm in 2020 for $6.0M.

Question 8

What was Mydecine Innovations Group's most recent acquisition?

Accepted Answer

Mydecine Innovations Group's most recent acquisition is NeuroPharm, announced June 2020 for $6.0M.

Question 9

What is the average deal size for Mydecine Innovations Group acquisitions?

Accepted Answer

The average disclosed deal size for Mydecine Innovations Group acquisitions is $6.0M.

Question 10

What is the median deal size for Mydecine Innovations Group acquisitions?

Accepted Answer

The median disclosed deal size for Mydecine Innovations Group acquisitions is $6.0M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has Mydecine Innovations Group spent on acquisitions?

Accepted Answer

Mydecine Innovations Group has spent at least $6.0M across its disclosed acquisitions (of 1 total deals; some prices are undisclosed).

Question 12

Which sector has Mydecine Innovations Group spent the most on?

Accepted Answer

Mydecine Innovations Group has committed the most disclosed capital to Biotechnology companies — about $6.0M across its deals in that sector.

Question 13

What sectors does Mydecine Innovations Group usually acquire in?

Accepted Answer

Mydecine Innovations Group most frequently acquires companies in Biotechnology, Health Care, Pharmaceutical.

Question 14

In which sector has Mydecine Innovations Group made the most acquisitions?

Accepted Answer

Mydecine Innovations Group has made the most acquisitions in the Biotechnology sector.

Question 15

In which year did Mydecine Innovations Group make the most acquisitions?

Accepted Answer

Mydecine Innovations Group made the most acquisitions in 2020, with 1 deal.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Mydecine Innovations Group

Company Details

Funding & Financials

IPO & Stock

Web Traffic

Technology & IP

Company Info

Signals & Scores

Acquisitions by Mydecine Innovations Group

Key People at Mydecine Innovations Group

Explore 200,000+ acquisitions — free

Recent News related to Mydecine Innovations Group

FAQs about Mydecine Innovations Group

People who checked this page also checked these